Cargando…

Galangin inhibits epithelial-mesenchymal transition and angiogenesis by downregulating CD44 in glioma

Galangin (3,5,7‑trihydroxyflavone), a natural flavonoid present in plants, has been reported to possess anticancer properties in various types of cancers comprising glioma. The underlying mechanism, however, has not been fully elucidated. CD44, a hall marker in glioma, has been reported to be associ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Daliang, Li, Dengfeng, Xu, Xiao-bing, Qiu, Shengcong, Luo, Shi, Qiu, Erning, Rong, Ziyun, Zhang, Ji, Zheng, Dahai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746128/ https://www.ncbi.nlm.nih.gov/pubmed/31528214 http://dx.doi.org/10.7150/jca.31487

Ejemplares similares

MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2
por: Liao, Hongzhan, et al.
Publicado: (2015)

Galangin inhibits cell invasion by suppressing the epithelial-mesenchymal transition and inducing apoptosis in renal cell carcinoma
por: CAO, JINGYI, et al.
Publicado: (2016)

The role of CD44 in epithelial–mesenchymal transition and cancer development
por: Xu, Hanxiao, et al.
Publicado: (2015)

MicroRNA-623 Inhibits Epithelial–Mesenchymal Transition to Attenuate Glioma Proliferation by Targeting TRIM44
por: Cui, Dawei, et al.
Publicado: (2020)

Galangin (GLN) Suppresses Proliferation, Migration, and Invasion of Human Glioblastoma Cells by Targeting Skp2-Induced Epithelial–Mesenchymal Transition (EMT)
por: Xiong, Yu, et al.
Publicado: (2020)

Raddeanin A inhibited epithelial-mesenchymal transition (EMT) and angiogenesis in glioblastoma by downregulating β-catenin expression
por: Wu, Bingshan, et al.
Publicado: (2021)

Exosomal LBH inhibits epithelial-mesenchymal transition and angiogenesis in nasopharyngeal carcinoma via downregulating VEGFA signaling
por: Wu, Anbiao, et al.
Publicado: (2022)

MMP-14 and CD44 in Epithelial-to-Mesenchymal Transition (EMT) in ovarian cancer
por: Vos, Maria Caroline, et al.
Publicado: (2016)

Downregulation of Ubiquitin-Specific Protease 22 Inhibits Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Osteosarcoma Cells
por: Zhang, Dengfeng, et al.
Publicado: (2017)

Disabled-2 downregulation promotes epithelial-to-mesenchymal transition
por: Martin, J C, et al.
Publicado: (2010)

Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling
por: Liu, Wei, et al.
Publicado: (2022)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of MicroRNA-21 Expression
por: Zou, Yang, et al.
Publicado: (2020)

MicroRNA-1297 downregulation inhibits breast cancer cell epithelial-mesenchymal transition and proliferation in a FA2H-dependent manner
por: Li, Hong, et al.
Publicado: (2020)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

Epithelial‐mesenchymal transition is activated in CD44‐positive malignant ascites tumor cells of gastrointestinal cancer
por: Nakano, Michitaka, et al.
Publicado: (2018)

Effect of PACAP on Hypoxia-Induced Angiogenesis and Epithelial–Mesenchymal Transition in Glioblastoma
por: Maugeri, Grazia, et al.
Publicado: (2021)

CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition
por: Banno, Asoka, et al.
Publicado: (2016)

miR-525-5p Modulates Proliferation and Epithelial–Mesenchymal Transition of Glioma by Targeting Stat-1
por: Xie, Peng, et al.
Publicado: (2020)

Mitochondrial SOD2 regulates epithelial-mesenchymal transition and cell populations defined by differential CD44 expression
por: Kinugasa, Hideaki, et al.
Publicado: (2015)

MicroRNA-328 inhibits migration and epithelial–mesenchymal transition by targeting CD44 in nasopharyngeal carcinoma cells
por: Lin, Chien-Hung, et al.
Publicado: (2018)

CD44v9 is associated with epithelial‐mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma
por: Taniguchi, Daisuke, et al.
Publicado: (2018)

Correction to: CD90(low) glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
por: Xue, Bing-zhou, et al.
Publicado: (2021)

Expression of CD44 and the survival in glioma: a meta-analysis
por: Wu, Gang, et al.
Publicado: (2020)

Galangin alleviates rheumatoid arthritis in rats by downregulating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway
por: Deng, Xiongwei, et al.
Publicado: (2022)

Procoagulant genes may affect angiogenesis, epithelial-mesenchymal transition, survival prognosis and tumor immune microenvironment in patients with urothelial carcinoma
por: Li, Bin, et al.
Publicado: (2023)

Calumenin contributes to epithelial-mesenchymal transition and predicts poor survival in glioma
por: Yang, Ying, et al.
Publicado: (2021)

ZAP isoforms regulate unfolded protein response and epithelial- mesenchymal transition
por: Ly, Phuong Thao, et al.
Publicado: (2022)

Inhibitory effects of metformin at low concentration on epithelial–mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells
por: Zhang, Rongrong, et al.
Publicado: (2015)

Afadin Downregulation by Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Gastric Cells
por: Marques, Miguel Sardinha, et al.
Publicado: (2018)

Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer
por: Wang, Fang, et al.
Publicado: (2022)

Downregulation of iNOS/NO Promotes Epithelial–Mesenchymal Transition and Metastasis in Colorectal Cancer
por: Du, Qiang, et al.
Publicado: (2023)

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer
por: Dong, Bo, et al.
Publicado: (2020)

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition
por: Gao, Yuan, et al.
Publicado: (2015)

OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition
por: Covert, Hunter, et al.
Publicado: (2019)

CD44 Staining of Cancer Stem-Like Cells Is Influenced by Down-Regulation of CD44 Variant Isoforms and Up-Regulation of the Standard CD44 Isoform in the Population of Cells That Have Undergone Epithelial-to-Mesenchymal Transition
por: Biddle, Adrian, et al.
Publicado: (2013)

Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation
por: Qiu, Feng, et al.
Publicado: (2022)

Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
por: Tsiampali, Julia, et al.
Publicado: (2020)

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression
por: He, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jc0veplndc0hs23m99cneqha1f